However, the re-expression of KAT6A neutralized the influence of KAT6A inhibition on apoptosis in ovarian cancer cells (Figure 6F), indicating that KAT6A promotes ovarian cancer cell resistance to cisplatin treatment. This evidence concerns the gene KAT6A and ovarian cancer.